» Authors » Chun-Lei Shi

Chun-Lei Shi

Explore the profile of Chun-Lei Shi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi C, Xin X, Zhang J
Comput Methods Programs Biomed . 2022 Jan; 215:106615. PMID: 35016084
Background And Objective: Computer aided diagnosis technology has been widely used to diagnose autism spectrum disorder (ASD) from neural images. The performance of the model usually depends largely on a...
2.
Zhang X, Song L, Wang P, Wang L, Li Y, Wang Y, et al.
Acta Haematol . 2019 Aug; 143(2):124-130. PMID: 31382264
Objective: The predictive value of pre-autologous stem cell transplantation (pre-ASCT) positron emission tomography/computed tomography (PET/CT) scans according to different criteria remains elusive in patients with diffuse large B-cell lymphoma (DLBCL)....
3.
Zhang D, Gan R, Farha A, Kim G, Yang Q, Shi X, et al.
Microorganisms . 2019 Jun; 7(6). PMID: 31146495
Although spice extracts are well known to exhibit antibacterial properties, there is lack of a comprehensive evaluation of the antibacterial effect of spices against antibiotic-resistant bacteria. In the present study,...
4.
Gu A, Wang W, Chen W, Shi C, Lu J, Han J
Int J Clin Exp Med . 2015 Mar; 8(1):145-54. PMID: 25784983
Objective: To evaluate the correlation between genetic polymorphisms in x-ray repair cross complementing group 1 (XRCC1) and sensitivity to platinum-based chemotherapy drugs in patients with non-small cell lung cancer. Methods:...
5.
Shi C, Li R, Xiong L, Gu A, Han B, Gu W
Tumour Biol . 2013 Mar; 34(3):1819-24. PMID: 23526128
X-ray repair cross-complementing protein 3 (XRCC3) belongs to DNA double-strand break repair pathway and XRCC3 rs861539 (C > T) polymorphism has been suspected with lung cancer risk. However, results from...
6.
Han B, Xiu Q, Wang H, Shen J, Gu A, Luo Y, et al.
Zhonghua Zhong Liu Za Zhi . 2012 Feb; 33(11):854-9. PMID: 22335953
Objective: To analyze the efficacy and quality of life and safety for paclitaxel and carboplatin (TC) and TC combined with endostar in the treatment of advanced non-small cell lung cancer...
7.
Zhang X, Dong Q, Huang J, Huang A, Shi C, Jin B, et al.
J Surg Oncol . 2010 Sep; 102(7):856-62. PMID: 20818602
Introduction: The purpose of the present study was to detect the presence of BASC-like stem cell-related indicators, such as clara cell secretory protein (CCSP), Octamer-4 (OCT4) and Bmi-1, and evaluate...
8.
Shi C, Zhang X, Han B, He W, Shen J, Chu T
Med Oncol . 2010 Jul; 28(4):1441-6. PMID: 20661664
The detection and diagnosis of small-sized (2 cm or less) non-small cell lung cancer (NSCLC) has increased with the development of computed tomography (CT). Over 80% of 5-year survival rate...
9.
Gu A, Wang H, Shi C, Xiong L, Gao Z, Han B
Zhonghua Zhong Liu Za Zhi . 2010 Mar; 32(1):71-4. PMID: 20211075
Objective: To evaluate the efficacy and safety of gefitinib for the treatment of advanced non-small cell lung cancer (NSCLC). Methods: 125 patients with advanced NSCLC who had failed or not...